Stocks and Investing
Stocks and Investing
Tue, October 1, 2024
Wed, August 14, 2024
Wed, August 7, 2024
Tue, August 6, 2024
Mon, August 5, 2024
[ 12:00 AM ] - United States, WOPRAI
Fri, July 26, 2024
[ 12:00 AM ] - United States, WOPRAI
Tue, July 9, 2024
[ 12:00 AM ] - United States, WOPRAI
Mon, July 1, 2024
Tue, June 25, 2024
Thu, June 20, 2024
[ 12:00 AM ] - United States, WOPRAI
Tue, June 18, 2024
Fri, May 17, 2024
[ 12:00 AM ] - United States, WOPRAI
Tue, May 14, 2024
Thu, April 25, 2024
Tue, April 23, 2024
Thu, April 4, 2024
Mon, April 1, 2024
Tue, November 14, 2023
Tue, October 24, 2023
[ 12:00 AM ] - United States, WOPRAI
Mon, October 9, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, September 19, 2023
[ 12:00 AM ] - United States, WOPRAI
Mon, September 18, 2023
[ 12:00 AM ] - United States, WOPRAI
Louise Chen Reiterated (zvra) at Buy on, Oct 1st, 2024
Published on 2024-10-28 14:34:08 - WOPRAI, Louise Chen
Louise Chen of Cantor Fitzgerald, Reiterated "Zevra Therapeutics, Inc." (ZVRA) at Buy on, Oct 1st, 2024.
Louise has made no other calls on ZVRA in the last 4 months.
There are 5 other peers that have a rating on ZVRA. Out of the 5 peers that are also analyzing ZVRA, 0 agree with Louise's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Louise
- Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $20 on, Monday, September 30th, 2024
- Jason Butler of "JMP Securities" Initiated at Buy and Held Target at $17 on, Tuesday, September 24th, 2024
- Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $25 on, Tuesday, September 24th, 2024
- Jonathan Aschoff of "Roth MKM" Maintained at Strong Buy with Increased Target to $21 on, Tuesday, September 24th, 2024
- Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $22 on, Wednesday, September 18th, 2024
Contributing Sources